Normal function · from ai-gene-review (Q9UHD2, commit 79fe13b38970) · AI-generated, not KB evidence

TBK1 (TANK-binding kinase 1) is a cytoplasmic non-canonical IKB kinase (IKK)-related serine/threonine protein kinase. Its domain architecture comprises an N-terminal protein kinase domain, a ubiquitin-like domain (ULD), a scaffold/dimerization domain, and a C-terminal coiled-coil region that mediates homodimerization; the active kinase is generated by trans-autophosphorylation at Ser172. TBK1 is a master kinase of innate antiviral immunity: downstream of cytoplasmic nucleic-acid sensors (RIG-I/MDA5 via MAVS; cGAS via STING1) and endosomal Toll-like receptors (TLR3/TLR4 via TRIF/TICAM1), TBK1 phosphorylates these adaptor proteins on their pLxIS motif to recruit and then phosphorylate the transcription factors IRF3 and IRF7, driving their dimerization, nuclear translocation, and induction of type I interferons (IFN-alpha/IFN-beta) and other antiviral/pro-inflammatory genes. It is the kinase effector of the cGAS-STING DNA-sensing pathway and was originally identified as an NF-kappaB-activating kinase (binding the adaptor TANK), phosphorylating RELA/NFKBIA/IKBKB under particular conditions. TBK1 is also a central kinase of selective autophagy: it phosphorylates the autophagy cargo receptors OPTN/optineurin (Ser177), SQSTM1/p62, NDP52/CALCOCO2 and TAX1BP1 to enhance their ubiquitin- and LC3-binding and drive mitophagy and antibacterial xenophagy, and it phosphorylates SMCR8 (in the C9orf72-SMCR8 complex) and the ATG8 proteins MAP1LC3C and GABARAPL2 to promote autophagosome maturation. TBK1 assembles into kinase complexes with scaffolding adaptors AZI2/NAP1, TANK and TBKBP1/SINTBAD. Additional context-dependent roles include bidirectional regulation of mTORC1/mTORC2 signaling, AKT1 activation, and immune cell differentiation. TBK1 activity is antagonized by numerous viral proteins, and human mutations cause familial ALS/frontotemporal dementia (haploinsufficiency), normal-tension/primary open-angle glaucoma, herpes-simplex encephalopathy, and autoinflammatory disease.

Acts as a non-canonical IKK-related protein serine/threonine kinase, phosphorylating the innate adaptors MAVS, STING1 and TICAM1/TRIF and the transcription factors IRF3/IRF7 to induce type I interferons in the antiviral innate immune response, including the cGAS-STING DNA-sensing pathway.
Drives selective autophagy by phosphorylating autophagy cargo receptors (e.g. OPTN/optineurin on Ser177) and autophagy machinery (SMCR8, ATG8 proteins), enhancing receptor ubiquitin/LC3 binding and autophagosome maturation to mediate mitophagy and antibacterial xenophagy.
Functions as an NF-kappaB-activating IKK-related kinase, assembling with the adaptor TANK and phosphorylating RELA/NFKBIA/IKBKB under particular conditions to promote NF-kappaB-dependent gene expression.
In the knowledge base · computed from kb/ at build time

Disorders

Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.

DisorderRelationshipWhere the gene appears
Amyotrophic Lateral Sclerosis causative
mechanism: Impaired Autophagy
subtype: FTDALS4
scoped to subtype: FTDALS4
Tuberculosis untyped
Type I interferon signaling pathway
Viral Encephalitis untyped
ClinGen gene–disease validity · snapshot 2026-10-03 · matched to entries by MONDO

An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.

ClinGen diseaseMOIClassificationdismech entry
frontotemporal dementia and/or amyotrophic lateral sclerosis 4 MONDO:0014641 AD Definitive
2022-11-03
Mechanism modules · computed from kb/

Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.